Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CATVOTCMKTS:FFNTFOTCMKTS:MEDXFOTCMKTS:TGIFF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATV4Cable TV International$0.00+100.0%$0.00$0.00▼$0.00N/AN/A43.95 million shs9.05 million shsFFNTF4Front Ventures$0.00$0.00$0.00▼$0.11N/AN/A1.38 million shs497,050 shsMEDXFMedexus Pharmaceuticals$2.28-0.9%$1.99$1.18▼$3.88N/AN/A25,307 shs2,250 shsTGIFF1933 Industries$0.00-9.5%$0.00$0.00▼$0.01N/AN/A138,751 shs2,350 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATV4Cable TV International0.00%0.00%-33.33%-60.00%-86.21%FFNTF4Front Ventures0.00%+25.00%-66.67%-97.02%-99.44%MEDXFMedexus Pharmaceuticals0.00%+9.04%+22.07%+20.58%+95.62%TGIFF1933 Industries0.00%-5.00%-37.70%-43.28%-51.28%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCATV4Cable TV InternationalN/AN/AN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AN/AN/AMEDXFMedexus PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCATV4Cable TV International 0.00N/AN/AN/AFFNTF4Front Ventures 0.00N/AN/AN/AMEDXFMedexus Pharmaceuticals 4.00Strong BuyN/AN/ATGIFF1933 Industries 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCATV4Cable TV InternationalN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AMEDXFMedexus PharmaceuticalsN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCATV4Cable TV InternationalN/A-$0.01N/A∞N/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/A0.00∞N/AN/AN/AN/AN/AMEDXFMedexus PharmaceuticalsN/AN/A0.00∞N/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCATV4Cable TV InternationalN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AMEDXFMedexus PharmaceuticalsN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCATV4Cable TV InternationalN/AFFNTF4Front VenturesN/AMEDXFMedexus PharmaceuticalsN/ATGIFF1933 IndustriesN/AInsider OwnershipCompanyInsider OwnershipCATV4Cable TV InternationalN/AFFNTF4Front VenturesN/AMEDXFMedexus PharmaceuticalsN/ATGIFF1933 IndustriesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCATV4Cable TV International10N/AN/ANot OptionableFFNTF4Front Ventures460N/AN/ANot OptionableMEDXFMedexus Pharmaceuticals98N/AN/ANot OptionableTGIFF1933 Industries87N/AN/ANot OptionableMEDXF, TGIFF, CATV, and FFNTF HeadlinesRecent News About These Companies1933 Industries Reports Profit in Q3 2025 Amidst Industry ChallengesJune 16, 2025 | tipranks.com1933 Industries Reports Profit in Third Quarter 2025 Financial ResultsJune 16, 2025 | accessnewswire.com1933 Industries Inc. (OTCMKTS:TGIFF) Sees Large Decline in Short InterestJune 14, 2025 | americanbankingnews.com1933 Industries Completes Full Acquisition of AMA SubsidiaryJune 2, 2025 | tipranks.com1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production SubsidiaryJune 2, 2025 | accessnewswire.com1933 Industries Completes Acquisition of Remaining Interest in SubsidiaryMay 22, 2025 | tipranks.com1933 Industries To Complete Purchase of 9% Interest of Cultivation and Production SubsidiaryMay 22, 2025 | accessnewswire.com1933 Industries Stock Short Interest Report | OTC:TGIFF | BenzingaApril 21, 2025 | benzinga.com1933 sees uptick in revenue in NevadaApril 2, 2025 | greenmarketreport.com1933 Industries Reports Second Quarter 2025 Financial ResultsMarch 31, 2025 | accessnewswire.comCSE Bulletin: Reinstatement - 1933 Industries Inc. (TGIF)March 6, 2025 | newsfilecorp.com1933 Industries Inc.: 1933 Industries Announces First Quarter 2025 Financial ReportFebruary 28, 2025 | finanznachrichten.de1933 Industries Announces First Quarter 2025 Financial ReportFebruary 27, 2025 | accessnewswire.com1933 Industries Inc.: 1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 27, 2025 | finanznachrichten.de1933 Industries losses contract year-over-year, but company still in the redFebruary 26, 2025 | greenmarketreport.com1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 25, 2025 | accessnewswire.com1933 Industries Appoints New CFO and VP FinanceJanuary 31, 2025 | accessnewswire.com1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportJanuary 24, 2025 | accessnewswire.com1933 Industries Inc.: 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | finanznachrichten.de1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMEDXF, TGIFF, CATV, and FFNTF Company Descriptions4Cable TV International OTCMKTS:CATV$0.0002 +0.00 (+100.00%) As of 06/18/2025 11:48 AM Eastern4Cable TV International, Inc. provides specialty solutions to the cable television sector. It offers a suite of products comprising RF to Fiber (RF2F), a proprietary line of coax-to-fiber taps that enables cable operators to reach homes within their franchise authorized area; PowerMiser, a circuitry, which allows a low current 1 GHz amplifier and/or line extender to be constructed with a decrease in current power requirements; RF over Glass (RFoG) signal distribution technology that combines the existing cable TV infrastructure with fiber optics to reach the home; and Node+0 application, which combines the RFoG technology platform with its PowerMiser engineering to take fiber signal. The company also provides SOLAR-CATV that utilizes solar power and helps the operator extend service to areas not presently served without adding power sources; and Dynamically Scalable Return technology, which allows nodes, R-ONU's (RFoG optical network units) to adjust their return bandwidth by changing the channel lineup at the head end, as well as repair, testing, and upgrade services. It markets and sells its products through a network of dealers in the United States and Canada primarily to independent cable TV operators, as well as to multiple system operators. 4Cable TV International, Inc. was incorporated in 2007 and is based in Conway, South Carolina.4Front Ventures OTCMKTS:FFNTF$0.0005 0.00 (0.00%) As of 06/18/2025 02:43 PM Eastern4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.Medexus Pharmaceuticals OTCMKTS:MEDXF$2.28 -0.02 (-0.91%) As of 06/18/2025 11:54 AM EasternMedexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; and Gleolan, an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery. The company's products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, ciprofloxacin and flucinolone acetonide; Trispan, a triamcinolone hexacetonide injectable suspension; and Treosulfan, a bifunctional alkylating agent for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation. In addition, it offers over the counter products comprising Nyda, a topical revolutionary treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; Tricovel tablets with Biogenina to reduce hair shedding due to Telogen Eflluvium; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Toronto, Canada.1933 Industries OTCMKTS:TGIFF$0.0038 0.00 (-9.52%) As of 06/18/2025 02:32 PM Eastern1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
